Clinical Trial Update: Semaglutide Treatment for Hyperglycaemia After Renal Transplantation [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study of semaglutide for hyperglycemia in renal transplant recipients, including patients with primary non-functi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Renal Transplant Complications

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Hyperglycemia, Renal Transplant Complication Primary Non-Function | Phase 4 | Status: RECRUITING